EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Dialyzer reuse and mortality risk in patients with end-stage renal disease: a systematic review



Dialyzer reuse and mortality risk in patients with end-stage renal disease: a systematic review



American Journal of Nephrology 35(3): 249-258



Robust evidence about dialyzer reuse effects on mortality is not available. Our aim was to summarize the evidence for the effectiveness of dialyzer reuse compared to single use in patients with end-stage renal disease. We searched MEDLINE, Embase, CINAHL, SciELO, LILACS, USRDS ADR, universities' theses databases and annals of congress from major nephrology societies. Reviewers performed the study selection and data extraction independently. We used the GRADE approach to assess the quality of the evidence. Mortality was the primary outcome. A total of 1,190 studies were retrieved, and 14 were included in the review (n = 956,807 patients). The disinfectants used on dialyzer reprocessing were hypochlorite, formaldehyde, glutaraldehyde, and peracetic acid. The evidence available from the studies was of very low quality. Most studies found no differences between groups. In studies with statistically significant differences, these differences were not observed in all groups and they varied by the type of disinfectant, time of observation and treatment unit. No significant differences were identified for the superiority or inferiority of dialyzer reuse versus single use when assessing the mortality of patients with end-stage renal disease. Studies of higher quality, including randomized clinical trials, are required to provide conclusive evidence regarding the effectiveness and safety of dialyzer reuse.

(PDF emailed within 0-6 h: $19.90)

Accession: 052590239

Download citation: RISBibTeXText

PMID: 22353780

DOI: 10.1159/000336532



Related references

Effect of dialyzer membrane and dialyzer reuse on plasma lipid levels in end stage renal disease patients on hemodialysis. Journal of the American Society of Nephrology 7(9): 1494, 1996

Effect of dialyzer membrane and dialyzer reuse on serum lipid levels in end stage renal disease patients on hemodialysis. Journal of the American Society of Nephrology 6(3): 585, 1995

Effect of dialyzer membrane and dialyzer reuse on plasma lipid levels in end stage renal disease patients Results of a pilot study. Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 249A, Sept, 1997

Dialyzer reuse and the treatment of patients with end-stage renal disease by hemodialysis. Journal of the American Society of Nephrology 9(11): 2153-2156, 1998

Lack of adverse effect of hemodialysis and dialyzer reuse on beta-2 glycoprotein I levels in end stage renal disease patients. Journal of the American Society of Nephrology 7(9): 1417, 1996

Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis. Bmc Nephrology 17(1): 157-157, 2016

Lack of effect of hemodialysis and dialyzer reuse on plasma beta2 glycoprotein I levels in end stage renal disease patients Results of a pilot study. Journal Of The American Society Of Nephrology. 9(program And Abstr. Issue): 249a,., 1997

The Risk of Tumour Recurrence in Patients Undergoing Renal Transplantation for End-stage Renal Disease after Previous Treatment for a Urological Cancer: A Systematic Review. European Urology, 2017

Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the usrds dialysis morbidity and mortality study. American Journal of Kidney Diseases 37(2): 276-286, 2001

High Mortality Risk in Chronic Kidney Disease and End Stage Kidney Disease Patients with Clostridium Difficile Infection: A Systematic Review and Meta-analysis. Journal of Nature and Science 1(4): -, 2015

Risk of End-Stage Renal Disease in Patients With Lupus Nephritis, 1971-2015: A Systematic Review and Bayesian Meta-Analysis. Arthritis & Rheumatology 68(6): 1432-1441, 2016

Vitamin D deficiency and treatment versus risk of infection in end-stage renal disease patients under dialysis: a systematic review and meta-analysis. Nephrology, Dialysis, Transplantation, 2018

Dialyzer reuse impact on dialyzer efficiency, patient morbidity and mortality and cost effectiveness. Saudi Journal of Kidney Diseases and Transplantation 12(3): 305-311, 2008

The relationship between laboratory-based outcome measures and mortality in end-stage renal disease: a systematic review. Hemodialysis International. International Symposium on Home Hemodialysis 13(3): 347-359, 2010

Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis. Nephrology, Dialysis, Transplantation, 2017